Kathi Apostolidis: An impressively large and very promising project to study the immune system was announced

Kathi Apostolidis shared the following post by Davorka Sekulic, Medical Lead Immunology at Sanofi, on LinkedIn, adding the following:

“An impressively large and very promising project to study the immune system was announced. The HIP project, when fully deployed, together with genomics will shed new light into better understanding cancer.

The Human Immunome Project (HIP) is backed by an international consortium of companies, government agencies, and universities to probe thousands of immune variables in blood and tissue samples. The result will likely be the world’s largest and most comprehensive immunological database, a resource for scientists investigating immune system differences and how they influence our responses to vaccines and drugs and our vulnerability to illness.”

Quoting Davorka Sekulic’s post:

“The Human Immunome Project (HIP) will probe thousands of immune variables in blood and tissue samples of thousands of people creating the world’s largest and most comprehensive immunological database, a resource for scientists investigating immune system differences and how they influence our responses to vaccines and drugs and our vulnerability to illness.”

Read further.
Source: Kathi Apostolidis/LinkedIn and Davorka Sekulic/LinkedIn

Kathi Apostolidis is the Past President and Scientific Committee Chair of the European Cancer Patient Coalition, the largest European cancer patients’ organization, representing 347 associations in 47 EU and non-EU countries. As a twice breast cancer survivor, she was involved in breast cancer and cancer patient rights advocacy since 1995. She advocates for affordable, state-of-the-art cancer care, new therapies and cancer research. She represents ECPC at the EMA’s Patients and Consumers Working Group, she is member of the European Commission Expert Group on Cancer Control, participates as ECPC representative in Work Packages of the EU Joint Action on Cancer Control (CanCon). She is a member of the Cancer Patients Working Group of ESMO, of the Steering Committee of HTAi’s Patients and Citizens Involvement Sub-Group. At the national level, she is the founding member and President of the Hellenic Cancer Coalition-ELLOK, Chair of the Intergroup Committee for Cancer Patient Rights Advocacy/Greece (DEDIDIKA), a body linking 28 cancer patient organizations, she serves as a Deputy Board Member at KEFI-Association of Cancer Patients, Volunteers and Physicians/Greece, and is also member of other Greek & international cancer patient associations.